Franklin Resources
MYGN icon

Franklin Resources’s Myriad Genetics MYGN Stock Holding History

Franklin Resources’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
206,454
+100,171
+94% +$455K ﹤0.01% 2213
2026
Q1 		$478K Buy
106,283
+2,909
+3% +$15.2K ﹤0.01% 2483
2025
Q4 		$636K Buy
103,374
+2,714
+3% +$19.7K ﹤0.01% 2294
2025
Q3 		$728K Buy
100,660
+25,654
+34% +$152K ﹤0.01% 2266
2025
Q2 		$398K Buy
75,006
+21,888
+41% +$129K ﹤0.01% 2428
2025
Q1 		$471K Sell
53,118
-4,844
-8% -$58.2K ﹤0.01% 2285
2024
Q4 		$795K Sell
57,962
-93
-0.2% -$1.72K ﹤0.01% 2084
2024
Q3 		$1.46M Buy
58,055
+4,710
+9% +$128K ﹤0.01% 1835
2024
Q2 		$1.3M Buy
53,345
+7,233
+16% +$159K ﹤0.01% 1833
2024
Q1 		$983K Buy
46,112
+4,998
+12% +$107K ﹤0.01% 1960
2023
Q4 		$787K Sell
41,114
-1,457
-3% -$25.2K ﹤0.01% 1742
2023
Q3 		$683K Buy
42,571
+324
+0.8% +$6.17K ﹤0.01% 1761
2023
Q2 		$979K Buy
+42,247
New +$922K ﹤0.01% 1652

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's MYGN Position: Q2 2026 in Review

Franklin Resources increased its Myriad Genetics (MYGN) stake by 94% in Q2 2026, buying an estimated $455K and bringing the position to 206,454 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2213.

Franklin Resources first reported a position in MYGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.46M in Q3 2024. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Franklin Resources held 206,454 shares of Myriad Genetics worth $1.18M as of Q2 2026.
  • Franklin Resources bought 100,171 Myriad Genetics shares in Q2 2026, an estimated $455K.
  • Myriad Genetics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2213 holding.
  • Franklin Resources first reported a position in Myriad Genetics in Q2 2023 and has held it in 13 quarters since.
  • Franklin Resources's Myriad Genetics position peaked at $1.46M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.